Design
Review
Authors
Loading...
Natural compounds remain investigational for metabolic syndrome; leaves open efficacy pending prospective trials.
Key points are not available for this paper at this time.
Rochlani et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: